Compare DKS & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DKS | GKOS |
|---|---|---|
| Founded | 1948 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 9.7B |
| IPO Year | 2002 | 2015 |
| Metric | DKS | GKOS |
|---|---|---|
| Price | $140.08 | $221.87 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 27 | 13 |
| Target Price | $160.83 | ★ $242.46 |
| AVG Volume (30 Days) | ★ 2.3M | 1.7M |
| Earning Date | 11-24-2026 | 10-28-2026 |
| Dividend Yield | ★ 3.54% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 7.04 | N/A |
| Revenue | ★ $17,215,120,000.00 | $507,442,000.00 |
| Revenue This Year | $28.26 | $53.82 |
| Revenue Next Year | $2.54 | $28.60 |
| P/E Ratio | $20.97 | ★ N/A |
| Revenue Growth | 28.06 | ★ 32.33 |
| 52 Week Low | $120.15 | $83.78 |
| 52 Week High | $244.38 | $255.19 |
| Indicator | DKS | GKOS |
|---|---|---|
| Relative Strength Index (RSI) | 48.70 | 63.70 |
| Support Level | $132.55 | $147.72 |
| Resistance Level | $149.33 | N/A |
| Average True Range (ATR) | 5.42 | 13.13 |
| MACD | 0.02 | 4.22 |
| Stochastic Oscillator | 33.66 | 65.30 |
Dick's Sporting Goods is a retailer that offers sports and outdoor apparel, footwear, and equipment online and in physical stores. The company's legacy business includes more than 700 stores under its own name, more than 110 Golf Galaxy golf specialty stores, and about 50 outlet stores. In September 2025, Dick's acquired multinational retailer Foot Locker. With this move, Dick's added about 2,600 stores under the Foot Locker, Kids Foot Locker, Champs Sports, atmos, and WSS nameplates in North America, the Asia-Pacific, and EMEA—Europe, the Middle East, and Africa. The combined Dick's and Foot Locker has an annual sales base of more than $22 billion. Based in the Pittsburgh area, Dick's was founded in 1948 by the father of current executive chair and controlling shareholder Edward Stack.
Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.